To investigate whether the extent to which patients adhere to the Dutch dietary guidelines improves more in out clinic patients, with a positive iFOBT, who receive dietary and physical activity advice by the Eetscore during 3 months, than in out…
ID
Source
Brief title
Condition
- Malignant and unspecified neoplasms gastrointestinal NEC
- Lifestyle issues
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The main study parameter will be the overall score (0-90) of the Eetscore. Sub
scores of the Eetscore are available for the intake of 1) vegetables, 2) fruit,
3) dietary fibre, 4) saturated fatty acids, 5) trans fats, 6) fish, 7) sodium,
8) alcoholic beverages and in addition 9) physical activity.
Secondary outcome
Secondary study parameters will be BMI, abdominal circumference, body
composition and quality of life.
Background summary
At the Division of Human Nutrition, we developed a validated tool to support
dietary advice. With this tool, the Eetscore, we can assess diet quality by
evaluating to what extent someone*s intake complies with the dietary
guidelines. The Eetscore can be used to monitor the diet of healthy persons and
patients with a high risk of disease, disease or recurrence of diseases. Based
on the results of the evaluation the patients can receive automatically a
targeted dietary advice. The advantage of the tool is that it is much shorter
than existing food questionnaires, requires little time to fill out (5-10
minutes), gives feed-back to the patient by a score, and is easily applicable.
Hospital Gelderse Vallei, in cooperation with the Division of Human Nutrition,
is developing a care path for nutrition. It aims to provide better nutritional
care for patients before admission to the hospital, during hospital stay and
after their discharge from hospital. The Eetscore could support this carepath.
Study objective
To investigate whether the extent to which patients adhere to the Dutch dietary
guidelines improves more in out clinic patients, with a positive iFOBT, who
receive dietary and physical activity advice by the Eetscore during 3 months,
than in out clinic patients, with a positive iFOBT, who receive no advice.
Study design
The whole study will take 7 months. Four months are needed to recruit
participants and to carry out baseline measurements. These baseline
measurements consist of filling out the Eetscore and quality of life
questionnaire and measuring abdominal circumference and body composition.
After completion of the Eetscore questionnaire patients will receive randomly
either an advice via the Eetscore application (intervention) or no advice
(control). Then, 3 months after the baseline measurements the follow-up
measurements (t=3) will be carried out. Also 4 months are reserved for
performing these follow-up measurements. These follow-up measurements consist
of the same measurements as at baseline.
Intervention
A 3 months intervention with dietary and physical advice according to the
Eetscore.
Study burden and risks
Participants are asked to fill out the Eetscore questionnaire and a
questionnaire about their general health. In addition, they have to undergo
measurements of waist and body composition by bioimpedance at baseline and at
the end of the study. In between they will follow dietary and physical activity
advice.
Bomenweg 2
Wageningen 6703HD
NL
Bomenweg 2
Wageningen 6703HD
NL
Listed location countries
Age
Inclusion criteria
patient have a positive iFOBT,
patient have an e-mail account,
patient agree to do the intake interview
Exclusion criteria
patients will be excluded if they do not enter the colon care outpatient clinic via the screening,
patients will be excluded if theydo not have a Dutch eating pattern
patients will be excluded if theyhave an internal electronic device, such as a pacemaker.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
| Register | ID |
|---|---|
| CCMO | NL51456.081.14 |
| OMON | NL-OMON21544 |